EP2756061A4 - Compositions pour solubiliser des cellules et/ou un tissu - Google Patents

Compositions pour solubiliser des cellules et/ou un tissu

Info

Publication number
EP2756061A4
EP2756061A4 EP12876815.7A EP12876815A EP2756061A4 EP 2756061 A4 EP2756061 A4 EP 2756061A4 EP 12876815 A EP12876815 A EP 12876815A EP 2756061 A4 EP2756061 A4 EP 2756061A4
Authority
EP
European Patent Office
Prior art keywords
tissue
compositions
solubilizing cells
solubilizing
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12876815.7A
Other languages
German (de)
English (en)
Other versions
EP2756061A1 (fr
Inventor
Byeong Hee Hwang
Samir Mitragotri
Russell M Lebovitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Priority to EP16161790.7A priority Critical patent/EP3056559B1/fr
Publication of EP2756061A1 publication Critical patent/EP2756061A1/fr
Publication of EP2756061A4 publication Critical patent/EP2756061A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
EP12876815.7A 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu Withdrawn EP2756061A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16161790.7A EP3056559B1 (fr) 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/038169 WO2013172832A1 (fr) 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP16161790.7A Division EP3056559B1 (fr) 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu

Publications (2)

Publication Number Publication Date
EP2756061A1 EP2756061A1 (fr) 2014-07-23
EP2756061A4 true EP2756061A4 (fr) 2014-08-13

Family

ID=49584087

Family Applications (2)

Application Number Title Priority Date Filing Date
EP16161790.7A Active EP3056559B1 (fr) 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu
EP12876815.7A Withdrawn EP2756061A4 (fr) 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP16161790.7A Active EP3056559B1 (fr) 2012-05-16 2012-05-16 Compositions pour solubiliser des cellules et/ou un tissu

Country Status (10)

Country Link
EP (2) EP3056559B1 (fr)
JP (1) JP2015528691A (fr)
KR (1) KR102099487B1 (fr)
CN (1) CN104520418A (fr)
AU (2) AU2012380348B2 (fr)
BR (1) BR112014028239B1 (fr)
CA (1) CA2873707A1 (fr)
IN (1) IN2014MN02536A (fr)
MX (1) MX369625B (fr)
WO (1) WO2013172832A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006026248A1 (fr) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions et procedes faisant appel a des combinaisons de detergents zwitterioniques
US20070183936A1 (en) * 2003-08-01 2007-08-09 Newsam John M Apparatus and methods for evaluating the barrier properties of a membrane
WO2010093861A2 (fr) * 2009-02-13 2010-08-19 The Regents Of The University Of Calfornia Système, procédé et dispositif de diagnostic à partir de tissu

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5358492A (en) * 1976-11-08 1978-05-26 Kao Corp Anti-foggig agent composition with lng lasting effect
US5639630A (en) * 1995-05-16 1997-06-17 Bayer Corporation Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes
ES2191834T3 (es) * 1996-10-24 2003-09-16 Alza Corp Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
CN1207569C (zh) * 1997-08-04 2005-06-22 株式会社先端生命科学研究所 用于测定含病毒样品的方法、病毒测定方法和诊断试剂盒
US6589173B1 (en) 2000-07-17 2003-07-08 The Regents Of The University Of California Ultrasound system for disease detection and patient treatment
FR2848848B1 (fr) * 2002-12-19 2005-01-28 Oreal Composition de lavage des matieres keratiniques a base de tensioactif amphotere et de peg modifie par un groupe hydrophobe
US7186522B2 (en) * 2003-03-31 2007-03-06 Cytyc Corporation Papanicolau staining process
CN1901935A (zh) * 2003-12-30 2007-01-24 惠氏公司 具有改进耐受性的免疫原组合物中的疏水性蛋白调配物
JP4422550B2 (ja) * 2004-05-25 2010-02-24 日華化学株式会社 親水性フッ素樹脂粒子の製造方法
US8389582B2 (en) * 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
WO2009048681A2 (fr) * 2007-08-06 2009-04-16 The Regents Of The University Of California Procédés de diagnostic à base de tissus
WO2009131995A1 (fr) * 2008-04-21 2009-10-29 Nanobio Corporation Vaccin antigrippal à base de nanoémulsion
AU2009240389A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
US7700530B2 (en) * 2008-06-30 2010-04-20 Kimberly Clark Worldwide, Inc. Polysensorial personal care cleanser comprising a quaternary silicone surfactant
JP5382687B2 (ja) * 2008-11-12 2014-01-08 独立行政法人産業技術総合研究所 ルシフェリン−ルシフェラーゼ反応における発光強度の低下を抑制するための組成物及び方法
US20100226983A1 (en) * 2009-01-28 2010-09-09 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
US20120064136A1 (en) * 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070183936A1 (en) * 2003-08-01 2007-08-09 Newsam John M Apparatus and methods for evaluating the barrier properties of a membrane
WO2006026248A1 (fr) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions et procedes faisant appel a des combinaisons de detergents zwitterioniques
WO2010093861A2 (fr) * 2009-02-13 2010-08-19 The Regents Of The University Of Calfornia Système, procédé et dispositif de diagnostic à partir de tissu

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUANG ET AL: "Separation and measurement of desmosine and isodesmosine in vascular tissue hydrolysates by micellar electrokinetic capillary chromatography with a mixed micelle system", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, vol. 1175, no. 2, 4 November 2007 (2007-11-04), pages 294 - 296, XP022373514, ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2007.10.091 *
S. PALIWAL ET AL: "One-step acquisition of functional biomolecules from tissues", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 107, no. 33, 17 August 2010 (2010-08-17), pages 14627 - 14632, XP055124735, ISSN: 0027-8424, DOI: 10.1073/pnas.1004302107 *
See also references of WO2013172832A1 *

Also Published As

Publication number Publication date
AU2017203389A1 (en) 2017-06-08
EP3056559B1 (fr) 2019-07-10
BR112014028239A2 (pt) 2017-06-27
CA2873707A1 (fr) 2013-11-21
JP2015528691A (ja) 2015-10-01
MX369625B (es) 2019-11-14
EP3056559A2 (fr) 2016-08-17
BR112014028239B1 (pt) 2021-05-11
CN104520418A (zh) 2015-04-15
MX2014013794A (es) 2015-04-08
AU2012380348B2 (en) 2017-02-23
AU2012380348A1 (en) 2015-01-22
EP2756061A1 (fr) 2014-07-23
WO2013172832A1 (fr) 2013-11-21
IN2014MN02536A (fr) 2015-09-04
EP3056559A3 (fr) 2016-10-12
KR20150023394A (ko) 2015-03-05
KR102099487B1 (ko) 2020-04-09

Similar Documents

Publication Publication Date Title
HK1245130A1 (zh) 酶組合物及其用於創傷愈合的用途
IL252566A0 (en) Pharmacy preparations and methods
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
SG11201501184XA (en) Implant
EP2585084A4 (fr) Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci
EP2629742A4 (fr) Compositions de revitalisation capillaire et méthodes associées
IL238274A0 (en) Methods and preparations for local increase of body fat
EP2838880A4 (fr) Compositions et procédés pour une imagerie non invasive
EP2931324A4 (fr) Compositions et procédés de régénération tissulaire
GB201315350D0 (en) Methods and compositions
EP2844272A4 (fr) Méthodes et compositions pour l'augmentation des érythrocytes
IL236823A0 (en) Preparations for use in the treatment of bone defects
GB201315347D0 (en) Methods and compositions
HK1204947A1 (en) Sterilized composition
HK1201451A1 (en) Compositions and methods
EP2668044A4 (fr) Compositions et leur utilisation
GB201018650D0 (en) Methods and compositions
EP2852662A4 (fr) Compositions de virus herpétique et procédés associés
EP2895186A4 (fr) Compositions thérapeutiques et méthodes associées
GB201207882D0 (en) Implant
GB201208315D0 (en) Pharmaceutical methods and compositions
EP2756061A4 (fr) Compositions pour solubiliser des cellules et/ou un tissu
HUE032878T2 (hu) Bõrvédõ és bõrkiegyensúlyozó készítmény
GB201222619D0 (en) Surgical implant
GB201018651D0 (en) Methods and compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20140710

RIC1 Information provided on ipc code assigned before grant

Ipc: C11D 1/88 20060101AFI20140704BHEP

Ipc: C07K 1/14 20060101ALI20140704BHEP

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HWANG, BYEONG, HEE

Inventor name: LEBOVITZ, RUSSELL, M.

Inventor name: MITRAGOTRI, SAMIR

17Q First examination report despatched

Effective date: 20150616

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161014